Allarta Life Science

allarta.com

Allarta Life Science is a pre-clinical regenerative medicine company based in Hamilton, Ontario, Canada, specializing in the development of next-generation biomaterials for immune-privileged delivery of cells, stem cells, and biologics. Their proprietary platform technology aims to overcome immune rejection and prevent cell escape, with a focus on curative cell therapies, particularly for type 1 diabetes. Founded in 2019 by leading researchers in polymer science, Allarta has built a diverse team and an extensive network of collaborators, positioning itself as a key player in the regenerative medicine market.